Medicare’s 2027 Physician Fee Schedule: Will primary care finally be paid for what it actually does?

Primary care has spent decades being told it is “central” to the U.S. health system while watching the Medicare Physician Fee Schedule (PFS) reward procedures far more richly than the cognitive and coordination work that defines our daily practice.

With its proposed calendar year (CY) 2027 PFS, the Centers for Medicare & Medicaid Services (CMS) is signaling that Medicare wants to move the payment system more decisively toward primary and preventive care, longitudinal relationships and accountable care — of course, not without new complications and trade‑offs.

The key question for independent practices and physician‑led accountable care organizations (ACOs) is whether we will treat these changes as a marginal coding tweak or as an opportunity to finally get paid more accurately for the work we already do.

What is CMS really trying to do?

In its 2027 PFS fact sheet and proposed rule, CMS describes the package as a set of “modernizing” reforms designed to strengthen primary care, behavioral health and advance care planning, while continuing the transition from the traditional Merit-based Incentive Payment System (MIPS) to more coherent value‑based pathways.

Medicare is keeping two different payment “tracks” — one for for physicians participating in advanced value‑based alternative payment models (APMs)(APMs) and one for everyone else — because the law requires it.

In simple terms, both tracks will pay a little less per unit of service than they do now, mainly because a temporary bump in payments that Congress added for a few years is ending.

In the CY 2027 rule, physicians in qualifying advanced APM ACOs such as MSSP and the new LEAD Model would get more than the usual longitudinal‑care boost: The revamped G2211 modifier would provide a larger payment increase for their eligible E/M visits than the standard G2211 adjustment available to other clinicians. When they bill an eligible evaluation and management (E/M) visit that truly reflects ongoing, complex care, the new longitudinal modifier would increase the payment for that visit by about 32%, instead of the 16% applied to non‑APM clinicians.

Let’s do the math

Here’s a simple example to make that concrete:

Imagine a Medicare 99214 visit for a patient with a complex, long‑term case that normally pays around $135 in your locality today.

Under the 2027 proposal, a non‑APM physician who attaches the longitudinal modifier G2211 would get roughly a 16% bump, taking that visit into the $150-$160 range, depending on the final base rate and geography.

An ACO/APM physician using the same modifier for the same kind of longitudinal visit would get about a 32% bump, which could push that visit closer to $175-$180 on average.

The exact dollar amounts will vary with local fee schedules and final rule details, but the structure is clear: If you are in a qualifying advanced APM, Medicare is offering roughly double the longitudinal‑care boost compared with non‑APM peers. This is meant to reward teams that have already invested in accountable care infrastructure — care managers, data and coordination — and to reinforce the message that future Medicare payment growth is tied to outcomes and relationships, rather than isolated services.

On the quality side, CMS would continue moving away from traditional MIPS, adding new MIPS Value Pathways for diabetes and hypertension, and signaling that the old, fragmented reporting requirements will be sunset after the 2028 performance period.

Taken together, these moves are meant to simplify reporting, improve clinical alignment and push clinicians toward arrangements in which primary care and longitudinal outcomes matter more than raw volume.

The money: Small cuts, targeted gains

If your practice depends heavily on that Medicare payment formula, any drop in it just feels like yet another pay cut on top of years of being paid too little.

But this new 2027 proposal isn’t happening on its own. At the same time, Medicare has been adding special extra payments for services that primary care already provides, such as complex chronic care, behavioral health integration and care management work.

If you actually use those codes in a consistent, disciplined way, they can more than offset some of the basic fee cuts and significantly improve what you earn per patient.

MedPAC, the Medicare Payment Advisory Commission, has repeatedly noted that primary care’s share of total physician spending remains modest and has recommended more robust support through prospective or hybrid payment models.

In response, CMS has gradually added new chronic care management codes, behavioral health integration payments and complexity add‑ons, even as global conversion factors have drifted downward.

Analyses of these new codes show that comprehensive adoption — particularly in advanced primary care practices and ACOs — can significantly increase revenue per patient, especially for high‑need populations.

The challenge is that many independent practices either underuse the codes because of documentation concerns or lack the operational infrastructure to identify eligible patients and bill consistently.

The CY 2027 rule raises the stakes by tying more of the payment opportunity to advanced APM participation and by refining one of the most important primary care add‑on codes: G2211.

G2211: From add‑on code to primary care signal

G2211 is a Healthcare Common Procedure Coding System add‑on code designed to recognize the complexity of E/M visits that are part of longitudinal care, where the physician or other qualified health professional serves as the continuing focal point for a patient’s medical needs or manages a serious or complex chronic condition.

Under this new proposal, Medicare is basically trying to make G2211 easier to use and more closely tied to the actual visit, rather than feeling like a confusing extra code.

Here’s the idea in very simple terms:

Today, G2211 is a separate add‑on code.

You bill your office or home E/M visit, then add G2211 on a second line when the visit reflects ongoing, relationship‑based care or management of serious, complex conditions. Under the proposal, Medicare would turn G2211 into more of a “boost” attached directly to the visit. Instead of a separate flat dollar amount, you’d use a modifier that increases the payment for that visit by a set percentage when it’s truly part of longitudinal care.

What that means in practice:

You still have to meet the same clinical criteria because you’re the continuing focal point, managing complex/chronic issues over time. But operationally, it becomes simpler: one visit code with a modifier, rather than juggling an extra code line. The added payment scales with the level of the visit, so more complex longitudinal visits get a bigger bump than simpler ones.

In short, Medicare is keeping the concept of “pay extra when the visit is part of ongoing, complex care,” but changing G2211 from a stand-alone add‑on code into a built‑in percentage increase on appropriate visits, which should make it more intuitive and more routinely used in primary care workflows.

G2211: New packaging, same payoff for providers not in an APM?

Under the proposal, Medicare would stop paying for G2211 as a separate add‑on code and instead use a new modifier that boosts payment for eligible longitudinal visits by about 16%. On paper, that sounds like a big win for primary care, but when you plug in typical current numbers, the actual bump is modest.

Take a common scenario: a 99214-coded office visit for a patient with a long‑term, complex case that you’ve managed for years. Today, Medicare pays roughly in the mid‑$130s for 99214 in many markets, and if you correctly add G2211, you might get an extra $15-$17, bringing the total close to $150-$152. Under the proposed 16% modifier, you would still start from a slightly lower base 99214 payment (because of the conversion factor decrease) and then add a 16% boost. In many localities, that ends up in roughly the same ballpark as today’s 99214 plus G2211 total, which is not a dramatic increase.

The key nuance for frontline primary care is that the new modifier changes how additional payment is applied — linking it more directly to the visit level and simplifying billing. But it does not, by itself, create a meaningful new revenue stream. At roughly a 16% increase, the modifier largely substitutes for the current G2211 add-on, rather than materially increasing total payment for complex, longitudinal care. The broader strategic intent is clear: This is a transitional step designed to encourage movement into APMs, where total payment could increase by as much as 32%.

That reality drives the more practical question for primary care: Should they move into advanced alternative payment models, where CMS is signaling increases on the order of 32% for longitudinal, population‑based care? Recent data suggest that this is no longer a niche pathway — roughly half of primary care physicians are already qualified APM participants under Medicare, and more than 60% of physicians report that their practices receive at least some revenue from APMs such as ACOs, capitation, bundled payments or shared savings

Policy and advocacy: Don’t let this moment slip away

The CY 2027 proposal is a meaningful step, but not a cure‑all. The underlying drop in the basic Medicare payment formula still threatens practice stability despite targeted primary care add‑ons, and repeated cuts continue to raise solvency concerns. At the same time, the rule signals that CMS has finally responded to years of advocacy insisting that relationships, coordination and prevention be explicitly valued.

The fee schedule’s core idea — pay more clearly for longitudinal, relationship‑based care and complexity — is sound, but the numbers are mixed. The new G2211‑style modifier cleans up the structure and better reflects what primary care does. Yet at current levels, the gain per complex visit is modest for clinicians outside advanced APMs, while participation in advanced APMs can turn the same framework into a markedly more lucrative pathway for complex longitudinal care.

Without sustained pressure on CMS to strengthen the actual dollar amounts, the policy risks appearing supportive of primary care while, in practice, keeping payment and power tilted toward volume and procedures instead of the relational work at the heart of the specialty.

Robert Resnik, M.D., MBA, is a board-certified internal medicine physician practicing in Cary, North Carolina. He earned his medical degree from Eastern Virginia Medical School and completed his residency at East Carolina University. He also holds an MBA from Duke University.